Table 4 |
|
|
Canonical pathways identified in the combined analysis of genes differentially expressed between the transitions from normal prostate to primary nonmetastatic prostate cancer and from primary nonmetastatic to metastatic prostate cancer* |
|
|
Pathway |
-Log(P) |
|
|
|
|
Integrin signaling |
4.42 |
|
Hepatic fibrosis/hepatic stellate cell activation |
3.50 |
|
Actin cytoskeleton signaling |
3.27 |
|
Tight junction signaling |
3.16 |
|
Chemokine signaling |
3.10 |
|
Calcium signaling |
2.60 |
|
IGF-1 signaling |
2.54 |
|
Aryl hydrocarbon receptor signaling |
2.10 |
|
Regulation of actin-based motility by Rho |
2.10 |
|
Nitric oxide signaling in the cardiovascular system |
2.05 |
|
Beta-alanine metabolism |
2.03 |
|
Wnt/β-catenin signaling |
1.63 |
|
VEGF signaling |
1.63 |
|
p53 signaling |
1.48 |
|
NRF2-mediated oxidative stress response |
1.43 |
|
Arginine and proline metabolism |
1.42 |
|
Cardiac β-adrenergic signaling |
1.38 |
|
cAMP-mediated signaling |
1.38 |
|
Cell cycle: G2/M DNA damage checkpoint regulation |
1.33 |
|
|
|
|
*Lists of the genes for each pathway are shown in Additional file 8. |
|
|
Gorlov et al. BMC Medical Genomics 2009 2:48 doi:10.1186/1755-8794-2-48 |
|